Advances in Point of Care Tech Alter the Genetic Testing Landscape
How are advances in point-of-care testing altering the genetic testing landscape, and what does this mean for the clinical lab?
How are advances in point-of-care testing altering the genetic testing landscape, and what does this mean for the clinical lab?
The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests
A new capillary blood collection system, the BD MiniDraw™, can improve the testing experience for both labs and patients
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Owlstone Medical CEO discusses recent trends, the advantages of breath testing, and the challenges that must be met for wider clinical use.